Cleared Traditional

K102535 - ETEST TELAVANCIN IN 0.002-32 UG/ML AND 0.016-256 UG/ML (FDA 510(k) Clearance)

May 2011
Decision
255d
Days
Class 2
Risk

K102535 is an FDA 510(k) clearance for the ETEST TELAVANCIN IN 0.002-32 UG/ML AND 0.016-256 UG/ML. This device is classified as a Manual Antimicrobial Susceptibility Test Systems (Class II - Special Controls, product code JWY).

Submitted by Biomerieux S.A. (Craponne, FR). The FDA issued a Cleared decision on May 16, 2011, 255 days after receiving the submission on September 3, 2010.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1640.

Submission Details

510(k) Number K102535 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 03, 2010
Decision Date May 16, 2011
Days to Decision 255 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement

Device Classification

Product Code JWY - Manual Antimicrobial Susceptibility Test Systems
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.1640

Similar Devices - JWY Manual Antimicrobial Susceptibility Test Systems

All 28
MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL
K252114 · Liofilchem S. R. L. · Oct 2025
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Colistin in the dilution range of 0.12-16 ug/mL
K252062 · Thermo Fisher Scientific · Sep 2025
The Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Aztreonam/avibactam in the dilution range of 0.008/4 - 64/4 ug/mL
K250575 · Thermo Fisher Scientific · Sep 2025
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin in the dilution range of 0.25-256 ug/mL
K252014 · Thermo Fisher Scientific · Aug 2025
MTS Sulbactam-Durlobactam 0.004/4 - 64/4 µg/mL (SUD)
K251580 · Liofilchem S. R. L. · Aug 2025
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ciprofloxacin in the dilution range of 0.002-64 ug/mL
K250990 · Thermo Fisher Scientific · Jun 2025